Dr. Alim Ladha
Dr. Alim Ladha, along with his team of anesthesiologists, administer the ketamine infusions. Our anesthesiologists have experience with ketamine and understand how a patient will respond to the infusions during their time with us. They focus on providing top quality care according to the highest standards of excellence.
Dr. Ladha is the current Deputy Corporate Chief of Anesthesia at Lakeridge Health. He graduated in 2013 from the University of Toronto Anesthesia residency program. During his career as an anesthesiologist, he has worked in various leadership capacities to promote the well-being of his patients. He helped to integrate two large health-care systems in the Durham region and led the anesthesiology department through various quality improvement initiatives, which have had an impact on how anesthetic care is delivered by the health system. Dr. Ladha’s interests outside of work include acting, bicycling, playing basketball and spending time with his wife and children.
Dr. Jack Barkin
Senior Medical Advisor
Dr. Barkin graduated with honours from medical school at the University of Toronto, and is an Associate Professor at the University of Toronto’s Department of Surgery, and a surgeon at Humber River Hospital in Toronto.
He is a Fellow of the American College of Surgeons (FACS), a Fellow of the Royal College of Surgeons of Canada (FRCS), a Fellow of the International College of Surgeons (FICS) and a Diplomate of the American Board of Urology (DABU).
Dr. Barkin also has a Masters in Health Care Management and is one of a few Certified Canadian Physician Executives, which recognizes physician leadership and excellence. He is a founding partner and Medical Director at Toronto-based Can-Am HIFU (High Intensity Focused Ultrasound) prostate-cancer treatment clinic.
Dr. Barkin has been involved in clinical research for more than 25 years and has been the principal investigator in over 250 Canadian and international clinical drug trials. He served on numerous medical advisory boards and has been published extensively in medical journals.
Dr. Paul Garfinkel
Psychiatrist and Former CEO, Centre for Addiction and Mental Health, professor in Psychiatry at University of Toronto; Advisor
Dr. Paul Garfinkel is the founding President and former CEO at CAMH. He is currently Professor Emeritus, Department of Psychiatry, University of Toronto, and Staff Psychiatrist at CAMH, the Centre for Addiction and Mental Health.
Dr. Garfinkel serves on the Discipline Committee for the College of Physicians and Surgeons of Ontario, and was on the Governing Council for the Canadian Institutes of Health Research until 2018, chairing the latter’s Ethics Committee.
A researcher, clinician and administrator, Dr. Garfinkel is the author and editor of several books on eating disorders, as well as contributing over 150 peer reviewed articles more than 80 book chapters to the professional literature. He has taken a leading role in the advocacy of support for psychiatric science, professional education, and public education, fighting the stigma of mental illness and addiction and mentoring of younger scientists in psychiatric research.
In 1996, Dr. Garfinkel was elected to Fellowship in the Royal Society of Canada. In 2000, he received the Lifetime Achievement Award from the Academy for Eating Disorders. He received the Pacesetter Award from the Schizophrenia Society of Canada in 2004 and a Public Service Award from the Canadian Mental Health Association in 2009. The City of Toronto named a park, the Paul E. Garfinkel Park, in recognition of his service to the City, in 2009. He became an Officer of the Order of Canada in 2008.
Dr. Glen Brooks,
Director, NY Ketamine Infusions; Advisor
Dr. Glen Brooks founded NY Ketamine Infusions in New York City as one of the world’s first therapy centers dedicated exclusively to providing ketamine infusions.
To date, Dr. Brooks has helped more patients than any other provider, having treated more than 3,000 patients for major depressive disorder, generalized anxiety, obsessive-compulsive disorder and post-traumatic stress. Dr. Brooks, a U.S. Board Certified anesthesiologist, completed his training at Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, and taught at the Yale University School of Medicine.
Founder and CEO. Entrepreneur and Former Depression sufferer
Justin Davies is an entrepreneur based in Toronto. In 2004 he launched ATM Works, and in 2009 launched JD ATM, a successful enterprise that places ATMs and provides merchant services throughout the GTA. To the Toronto Ketamine Clinic, Davies brings his experience in building and running a successful company over the past 15 years, creating and developing his business from conception – raising capital, sales development and staffing. Davies graduated from York University with a BA in political science.
Davies has, over the past 20 years, experienced the despair of treatment-resistant depression. It wasn’t until he was introduced to IV Ketamine infusions in the U.S. that he experienced both immediate relief and a resurgence of a range of emotions that were otherwise unavailable. Having gone through a myriad of partially- to completely-ineffective treatments, he can personally testify to the effectiveness of ketamine infusions. Justin’s passion and commitment is to bring this life-saving treatment to Canadians who currently are suffering from major mood disorders and chronic mental-health conditions to provide a new range of opportunities to this population that is often plagued with hopelessness.
Like so many others, I had tried multiple antidepressant medications only to have a partial response or no response at all. I had dealt with my depression that way for over 20 years. It was when an unrelenting bout hit me in 2016 that I knew I had to find something new. I discovered intravenous ketamine infusions in the United States and I remember before my first infusion at a clinic in New York, I was so nervous and desperately hoped it would work. To say it was transformative is to understate it. The heaviness in my head and body dissolved and I felt a lightness that I had not felt in years. I was astounded. It was at that point I vowed that I would bring this treatment to our country.